Glycaemic control is a key component of the successful management of Type 1 and Type 2 diabetes mellitus. Hypoglycaemia is the limiting factor in the management of diabetes because current glucose-lowering regimens are imperfect, defences against decreasing glucose levels in Type 1 and probably Type
Transient neonatal diabetes mellitus type 1
β Scribed by Deborah J.G. Mackay; I. Karen Temple
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 123 KB
- Volume
- 154C
- Category
- Article
- ISSN
- 1552-4868
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Needle phobia in patients with Type 1 (insulin-dependent) diabetes mellitus is difficult to manage. We report a case of long-standing needle phobia in a patient with 33 years of Type 1 diabetes mellitus who has developed very few vascular complications. Further studies are required to identify the p
We investigated autonomic function in 58 children and young adults with Type 1 diabetes mellitus (aged 7-22 years, duration from 3 to 18, 8.6 Β± 3.4 years) and in 74 healthy controls (6-21 years) using power spectral analysis of blood pressure and heart rate in addition to conventional standard auton
Type 2 diabetes currently accounts for over 100 billion dollars in annual healthcare expenditure in the United States and 28 % of the national (Medicare) healthcare budget for elderly Americans. In our inner-city hospital, 20 % of all 950 beds are occupied by patients with diabetes; and 28-38 % of p
## Hypoglycaemia is an important complication of insulin treatment in Type 1 diabetes mellitus (DM). Pancreas transplantation couples glucose sensing and insulin secretion, attaining a distinctive advantage over insulin treatment. We tested whether successful transplantation can avoid hypoglycaemi